Ali Health and Beijing Merson Pharmaceutical have reached a strategic cooperation agreement.

On January 8th, Alibaba Health and Beijing Merson Pharmaceutical Technology Development Co., Ltd. reached a strategic cooperation agreement, jointly announcing that they will deepen their cooperation in the field of innovative pediatric specialty drugs. The two parties will collaborate deeply around the world's first externally applied innovative drug, BeiMeiJing, approved for the treatment of proliferative superficial infantile hemangioma, from patient education, public assistance to multi-channel launch.